ORIC Pharmaceuticals (ORIC) Stock Forecast & Price Prediction

Estimation of the future price movement of ORIC Pharmaceuticals stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target


Current $9.80

Concensus $16.25


Low $7.00

Median $18.50

High $21.00

Based on analysts projections #ORIC is expected to experience a positive growth trajectory over the next year.

The current average ORIC price target, as estimated by these analysts, is $16.25.

The predictions for the future ORIC stock price range from a low of $7.00 to a high of $21.00, highlighting the variability of market expectations for ORIC.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

ORIC stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
Robert Burns
H.C. Wainwright
March 21, 2024 Buy 21.00 14.59
David Nierengarten
Wedbush
March 12, 2024 Buy 20.00 14.63
Matthew Biegler
Oppenheimer
March 12, 2024 Buy 17.00 14.32
Yigel Nochomovitz
Citigroup
April 5, 2022 Sell 7.00 6.90

ORIC Pharmaceuticals (ORIC) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if ORIC Pharmaceuticals is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Neutral

Financial Scores

Updated on: 13/04/2024

Altman Z-Score: 10.0

Piotroski Score: 1.0

ESG Score

Updated on: 13/04/2024

Environmental: 61.1

Social: 63.6

Governance: 61.0

Financial Health

Updated on: 13/04/2024

DCF: Neutral

ROE: Strong Sell

ROA: Sell

Debt to equity ratio: Neutral

Price to earnings ratio: Sell

Price to book ratio: Buy

ORIC Discounted Cash Flow

Updated on: 13/04/2024

$0.256
Discounted Cash Flow Value


$9.800
Current Price

ORIC Revenues by Segment

Updated on: 13/04/2024

No available data

Revenue from Contract with Customer, Excluding Assessed Tax

ORIC Revenues by Region

Updated on: 13/04/2024

No available data

ORIC Notes Due

Updated on: 13/04/2024

CIKExchangeTitle

There are no data to display

ORIC Pharmaceuticals (ORIC) Social Sentiments

Monitoring bullish and bearish sentiments towards ORIC Pharmaceuticals on Twitter and Stocktwits could help to forecast an upward or downward trend in ORIC Pharmaceuticals stock price.

ORIC Pharmaceuticals: Shining a Light on Promising Stock Forecast in the Biotech Industry

ORIC Pharmaceuticals (ORIC), a biotech company operating in the androgen receptor antagonist space, is currently making waves as investors eagerly monitor their stock forecast. The California-based company focuses on creating treatments for various types of cancer. With research indicating that prostate cancer often originates from the androgen receptor activation, ORIC has developed chemical entities for reversing resistance to androgen receptor... Read more

ORIC Pharmaceuticals' Stock Prediction Generates Buzz in the Biotech Sector

The biotechnology sector is one of the most exciting areas of the stock market. Companies in this industry work to develop innovative solutions for a range of medical and environmental challenges using cutting-edge technology. One notable player in the biotech space is ORIC Pharmaceuticals (Biotechnology: ORIC), whose stock prediction has been generating buzz among investors recently. ORIC Pharmaceuticals is a... Read more